Patent application number | Description | Published |
20090321680 | Process and Apparatus for Utilizing Oxygen-Containing Polymers - A process is described for converting and utilizing oxygen-containing polymers to form hydrogen and alkali metal carbonates, in which the polymers are brought into intimate contact with a melt mixture of alkali metal hydroxide and alkali metal carbonate to form hydrogen and alkali metal carbonate, and the alkali metal carbonate formed is removed from the reaction mixture during the reaction and alkali metal hydroxide is optionally metered in. The reaction is preferably carried out under conditions which lie on a point on the Liquidus line of the system. It is possible in accordance with the invention to process natural or synthetic polymers, for example polyester, polyether, wood, etc. It is particularly suitable for processing fiber-reinforced composite materials. Also described is an apparatus for performing the process according to the invention. | 12-31-2009 |
20120076707 | Process and Apparatus for Utilizing Oxygen-Containing Polymers - A process is described for converting and utilizing oxygen-containing polymers to form hydrogen and alkali metal carbonates, in which the polymers are brought into intimate contact with a melt mixture of alkali metal hydroxide and alkali metal carbonate to form hydrogen and alkali metal carbonate, and the alkali metal carbonate formed is removed from the reaction mixture during the reaction and alkali metal hydroxide is optionally metered in. The reaction is preferably carried out under conditions which lie on a point on the Liquidus line of the system. It is possible in accordance with the invention to process natural or synthetic polymers, for example polyester, polyether, wood, etc. It is particularly suitable for processing fiber-reinforced composite materials. Also described is an apparatus for performing the process according to the invention. | 03-29-2012 |
20150094489 | METHOD FOR REACTING GLYCERIN TO FORM ORGANIC SALTS - The invention relates to a process for reacting glycerin wherein the glycerin is reacted at temperatures above 150° C. in an aqueous, liquid solution of Me hydroxide, wherein the concentration of the Me hydroxide is greater than the saturation concentration at room temperature, wherein Me is selected from the group consisting of alkali metals and alkaline earth metals and mixtures thereof, and said reaction affords at least one salt selected from the group consisting of formate, acetate, propionate, oxalate, lactate, butyrate, valerate, citrate, adipate, succinate, malate and carbonate and mixtures thereof and hydrogen gas (H | 04-02-2015 |
Patent application number | Description | Published |
20150052911 | METHOD FOR TRANSITIONING BETWEEN VEHICLE CLIMATE CONTROL SYSTEM MODES - A method for controlling transitions between activating and deactivating a vehicle air conditioner compressor is disclosed. In one example, displacement of the air conditioner compressor is adjusted before the air conditioner is coupled to an energy conversion device. The method may provide smooth transitions between different air conditioner compressor control modes. | 02-26-2015 |
20150122207 | VARIABLE DISPLACEMENT SOLENOID CONTROL - Methods are provided for improved control of valve activation/deactivation mechanisms. One example method comprises, adjusting an electromechanical actuator to actuate cylinder valve deactivation/activation mechanisms. The actuator is operated at multiple levels based on engine operating conditions. | 05-07-2015 |
20150285111 | CRANKCASE INTEGRITY BREACH DETECTION - Methods and systems are provided for using a crankcase vent tube pressure or flow sensor for diagnosing a location and nature of crankcase system integrity breach. The same sensor can also be used for diagnosing air filter plugging and PCV valve degradation. Use of an existing sensor to diagnose multiple engine components provides cost reduction and sensor compaction benefits. | 10-08-2015 |
20160003168 | SYSTEM AND METHOD FOR SELECTIVE CYLINDER DEACTIVATION - Embodiments for operating an engine with skip fire are provided. In one example, a method comprises during a skip fire mode or during a skip fire mode transition, port injecting a first fuel quantity to a cylinder of an engine, the first fuel quantity based on a first, predicted air charge amount for the cylinder and lean of a desired air-fuel ratio, and direct injecting a second fuel quantity to the cylinder, the second fuel quantity based on the first fuel quantity and a second, calculated air charge amount for the cylinder. | 01-07-2016 |
20160097355 | CRANKCASE INTEGRITY BREACH DETECTION - Methods and systems are provided for using a crankcase vent tube pressure or flow sensor for diagnosing a location and nature of crankcase system integrity breach. Integrated CVT pressure readings are used to diagnose disconnection of the CVT on the air intake side and distinguish from disconnection on the crankcase side. Use of integrated pressure readings allows for a more reliable and quicker diagnosis even at lower engine airflows. | 04-07-2016 |
Patent application number | Description | Published |
20120021929 | USE OF DPPIV/SEPRASE AS A MARKER FOR CANCER - Described is a method aiding in the assessment of the presence of cancer. The method uses the soluble DPPIV/seprase protein complex (DPPIV/seprase) as a universal marker of different cancer types. Measurement of DPPIV/seprase complex can, e.g., be used in the early detection or diagnosis of cancer or in the surveillance of patients who undergo surgery. | 01-26-2012 |
20130344504 | NNMT AS A MARKER FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) - An in vitro method aiding in the assessment of chronic obstructive pulmonary disease (COPD). The disclosure further relates to a method for assessing COPD from a sample, derived from an individual, by measuring the protein NNMT in said sample in vitro. | 12-26-2013 |
20130344506 | SEPRASE AS A MARKER FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) - An in vitro method aiding in the assessment of chronic obstructive pulmonary disease (COPD). The disclosure further relates to a method for assessing COPD from a sample, derived from an individual, by measuring the protein Seprase in said sample in vitro. | 12-26-2013 |
20150192587 | USE OF PROTEIN S100A12 AS A MARKER FOR COLORECTAL CANCER - The present invention relates to the diagnosis of colorectal cancer. It discloses the use of protein S100A12 in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a stool sample, derived from an individual by measuring S100A12 in said sample. Measurement of S100A12 can, e.g., be used in the early detection or diagnosis of colorectal cancer. | 07-09-2015 |
Patent application number | Description | Published |
20090263841 | USE OF NNMT AS A MARKER FOR LUNG CANCER - The present invention relates to the assessment of lung cancer. It discloses the use of protein NNMT in the assessment of lung cancer. It also relates to a method for assessing lung cancer by measuring NNMT in vitro in a liquid sample derived from an individual. Measurement of NNMT can, e.g., be used in the early detection or in the follow-up of patients with lung cancer. | 10-22-2009 |
20090270272 | ASSESSING RISK OF DISEASE PROGRESSION IN RHEUMATOID ARTHRITIS PATIENTS - Disclosed is an in vitro method aiding in the further assessment of patients suffering from rheumatoid arthritis. The method especially is used in assessing whether an RA patient is at risk of disease progression. The method is for example practiced by analyzing biochemical markers, comprising measuring in a sample the concentration of at least C-reactive protein (CRP) and interleukin-6 and correlating the concentrations determined to the likelihood of an underlying rapidly progressing form of RA. A patient at high risk of a rapidly progressing disease might be a patient in need for treatment or if already treated in need for a different and more effective treatment. The invention also relates to the use of a marker panel comprising C-reactive protein and interleukin-6 in the assessment of a patient with rheumatoid arthritis and it teaches a protein array device and kit, respectively, for performing the method of the invention. | 10-29-2009 |
20090286328 | USE OF PROTEIN S100A12 AS A MARKER FOR COLORECTAL CANCER - The present invention relates to the diagnosis of colorectal cancer. It discloses the use of protein S100A12 in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a stool sample, derived from an individual by measuring S100A12 in said sample. Measurement of S100A12 can, e.g., be used in the early detection or diagnosis of colorectal cancer. | 11-19-2009 |
20100159479 | TIMP-1 AS A MARKER FOR COLORECTAL CANCER - The present invention relates to the diagnosis of colorectal cancer. It discloses the use of protein TIMP-1 (tissue inhibitor of metalloproteinase 1) as a marker molecule in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a stool sample, derived from an individual, the method involving measuring TIMP-1 in the sample. Measurement of TIMP-1 can, e.g., be used in the early detection or diagnosis of colorectal cancer. | 06-24-2010 |
20100240068 | MARKER PANEL FOR COLORECTAL CANCER - The present invention relates to a method for assessing colorectal cancer (CRC) in vitro including measuring in a sample the concentration and/or activity of a seprase polypeptide and/or fragments thereof and of either anti-p53 and/or osteopontin and/or ferritin, of optionally one or more other marker of CRC, and using the combined measurement result in the assessment of CRC. Furthermore, it especially relates to a method for assessing CRC from a liquid sample, derived from an individual by measuring seprase and at least anti-p53, ferritin and/or osteopontin in the sample. The method according to the present invention can, e.g., be used in the early detection of cancer by screening of asymptomatic individuals or in the surveillance of patients who undergo surgery. | 09-23-2010 |
20100240081 | SEPRASE AS A MARKER FOR CANCER - The present invention relates to a method aiding in the assessment of cancer. It discloses the use of the human fibroblast activation protein (FAP/seprase) as a universal marker of different cancer types. Seprase aids in the assessment of pulmonary or lung cancer (LC) or of colon cancer, e.g., of non-small cell lung carcinoma (NSCLC) or colorectal cancer (CRC), but also likely of other specific types of cancer. Such specific cancer types are, e.g., esophagus, head and neck cancer, stomach cancer, bile duct cancer, pancreas cancer, kidney cancer, cervix cancer, ovary cancer, breast cancer, bladder cancer, endometrium cancer or prostate cancer. Furthermore, it especially relates to a method for assessing cancer from a liquid sample, derived from an individual by measuring seprase in said sample. Measurement of seprase can, e.g., be used in the early detection of cancer or in the surveillance of patients who undergo surgery. | 09-23-2010 |